EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access · CC BY 4.0

Sample size calculation for clinical trials analyzed with the meta‐analytic‐predictive approach

Hongchao Qi iD, Dimitris Rizopoulos, Joost van Rosmalen

Research Synthesis Methods · 2023-05 · 14 (3) · 396-413

DOI: 10.1002/jrsm.1618 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Research Synthesis Methods, online erschienen am 14.01.2023. Verfasst von Hongchao Qi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics, Erasmus University Medical Center, Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Models, Statistical, Research Design. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of California, San Diego, Alzheimer's Disease Cooperative Study (ADCS), National Institutes of Aging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The meta‐analytic‐predictive (MAP) approach is a Bayesian method to incorporate historical controls in new trials that aims to increase the statistical power and reduce the required sample size. Here we investigate how to calculate the sample size of the new trial when historical data is available, and the MAP approach is used in the analysis. In previous applications of the MAP approach, the prior effective sample size (ESS) acted as a metric to quantify the number of subjects the historical information is worth. However, the validity of using the prior ESS in sample size calculation (i.e., reducing the number of randomized controls by the derived prior ESS) is questionable, because different approaches may yield different values for prior ESS. In this work, we propose a straightforward Monte Carlo approach to calculate the sample size that achieves the desired power in the new trial given available historical controls. To make full use of the available historical information to simulate the new trial data, the control parameters are not taken as a point estimate but sampled from the MAP prior. These sampled control parameters and the MAP prior based on the historical data are then used to derive the statistical power for the treatment effect and the resulting required sample size. The proposed sample size calculation approach is illustrated with real‐life data sets with different outcomes from three studies. The results show that this approach to calculating the required sample size for the MAP analysis is straightforward and generic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Models, StatisticalResearch DesignHumansSample SizeBayes TheoremMonte Carlo MethodComputer Simulation

Stichwörter der Autor:innen

Bayesian statisticsdynamic borrowingmeta-analytic-predictivesample size calculation

Autor:innen und Institutionen

  • Department of Biostatistics, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands.

ORCID-Profile: Hongchao Qi

Förderung

  • University of California, San Diego
  • Alzheimer's Disease Cooperative Study (ADCS)
  • National Institutes of Aging

Zitieren

APA

Qi, H., Rizopoulos, D., & van Rosmalen, J. (2023). Sample size calculation for clinical trials analyzed with the meta‐analytic‐predictive approach. Research Synthesis Methods, 14(3), 396-413. https://doi.org/10.1002/jrsm.1618

Vancouver

Qi H, Rizopoulos D, van Rosmalen J. Sample size calculation for clinical trials analyzed with the meta‐analytic‐predictive approach. Research Synthesis Methods. 2023;14(3):396-413. doi:10.1002/jrsm.1618

BibTeX
@article{Qi2023,
  author = {Qi, Hongchao and Rizopoulos, Dimitris and van Rosmalen, Joost},
  title = {Sample size calculation for clinical trials analyzed with the meta‐analytic‐predictive approach},
  journal = {Research Synthesis Methods},
  year = {2023},
  volume = {14},
  number = {3},
  pages = {396--413},
  doi = {10.1002/jrsm.1618}
}
Kostenlos starten →